General MedicationsOPHTHALMICGeneric
BRINZOLAMIDE
BRINZOLAMIDE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview BRINZOLAMIDE is listed in Drugs@FDA under application 211914 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BRINZOLAMIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1% Sponsor PADAGIS US Submission history Latest submission status date: 2023-07-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview BRINZOLAMIDE is listed in Drugs@FDA under application 211914 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BRINZOLAMIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1% Sponsor PADAGIS US Submission history Latest submission status date: 2023-07-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.